US20170127941A1 - Implant for determining intraocular pressure - Google Patents
Implant for determining intraocular pressure Download PDFInfo
- Publication number
- US20170127941A1 US20170127941A1 US15/319,294 US201515319294A US2017127941A1 US 20170127941 A1 US20170127941 A1 US 20170127941A1 US 201515319294 A US201515319294 A US 201515319294A US 2017127941 A1 US2017127941 A1 US 2017127941A1
- Authority
- US
- United States
- Prior art keywords
- implant
- eye
- data
- pressure sensor
- implant according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007943 implant Substances 0.000 title claims abstract description 105
- 230000004410 intraocular pressure Effects 0.000 title claims abstract description 21
- 210000003161 choroid Anatomy 0.000 claims abstract description 28
- 210000003786 sclera Anatomy 0.000 claims abstract description 25
- 239000012528 membrane Substances 0.000 claims description 10
- 238000005259 measurement Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 238000009530 blood pressure measurement Methods 0.000 claims description 7
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000011241 protective layer Substances 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims description 2
- 238000005345 coagulation Methods 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000004434 saccadic eye movement Effects 0.000 claims description 2
- 230000009772 tissue formation Effects 0.000 claims description 2
- 230000001627 detrimental effect Effects 0.000 claims 1
- 210000001508 eye Anatomy 0.000 description 45
- 238000002513 implantation Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 208000024304 Choroidal Effusions Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 210000002159 anterior chamber Anatomy 0.000 description 2
- 239000003364 biologic glue Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010068516 Encapsulation reaction Diseases 0.000 description 1
- 208000020564 Eye injury Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000278713 Theora Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008397 ocular pathology Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/16—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0008—Temperature signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
Definitions
- the present invention relates to an implant for determining intraocular pressure, comprising at least one electronic pressure sensor for measuring the intraocular pressure, at least one microchip that is connected to the pressure sensor, and at least one antenna that is connected to the microchip, the microchip generating digitally encoded data from the electrical signals of the pressure sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye, and said components being accommodated in a small housing, the outer dimensions of which are limited such that the implant can be positioned between the sclera and choroid of the eye.
- U.S. Pat. No. 8,475,374 B2 discloses an implant of this type.
- This known implant comprises an artificial drainage tube or is in contact with an artificial drainage tube for watery ocular fluid in order to measure the pressure of the outflowing ocular fluid.
- an artificial drainage tube is associated with a considerable and risky intervention in the eye.
- U.S. Pat. No. 7,824,423 B2 discloses a surgical tool for inserting implants into the eye. Moreover, this US patent discloses inserting implants into the eye that are used for scleral prosthesis and that increase the working range of the ciliary muscles in a purely mechanical manner in order to make it easier for the eye treated in this way to focus on nearby objects if the amplitude of accommodation has already declined due to age.
- the object of the invention is to provide an implant for determining intraocular pressure that can be implanted into the eye with little intervention and that transmits measurement data of the highly accurately measured intraocular pressure to a receiver located outside the eye.
- the pressure sensor is accommodated on the outer housing side that is brought into contact with the choroid in the eye.
- the implant according to the invention can be implanted into human or animal eyes in a minimally invasive manner and can remain there as a long-term implant.
- the implant is designed according to the invention such that it can be accommodated in a suprachoroidal cavity of the eye created for positioning the implant between the sclera and choroid, where said implant does not interfere with the functioning of the eye. Neither an artificial lens nor an artificial drainage tube for the ocular fluid is necessary. Nevertheless, the contact of the pressure sensor on the choroid ensures that the intraocular pressure is applied to the pressure sensor and can be measured accurately.
- the implantation is carried out either by means of a separate implantation procedure or in combination with other ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
- ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
- the outer housing side equipped with the pressure sensor to comprise a flexible membrane in the region of the pressure sensor as a protective layer against ingress of fluid, the intraocular pressure acting on the pressure sensor via the choroid and the membrane.
- the flexible membrane ensures precise transfer of the intraocular pressure, which could otherwise be distorted by housing-induced mechanical tensions if a less flexible housing material were used.
- the implant housing is flat and elongate, preferably in the form of an ellipsoid or cuboid having rounded corners and edges. By rounding off the edges and corners, eye injuries can be prevented.
- the implant In order to preserve ocular integrity, the implant must be as flat as possible, since relatively little space can be created between the sclera and the choroid. The thickness of the implant is therefore the smallest dimension thereof and should be less than 2 mm if possible.
- the front face should not be too big either, in order for the scleral incision necessary for inserting the implant to be as small as possible.
- the width of the implant is therefore preferably less than 3.5 mm.
- the largest dimension is the length of the implant, which should preferably be less than 7 mm in order to minimise the biomechanical influences on the eye as well as on the implant.
- the implant Due to its flat shape, the implant cannot rotate about its longitudinal axis within the pocket between the sclera and choroid in the eye. Only rotations about the vertical axis (see direction of rotation 32 in FIG. 3 ) are possible. These rotations can be performed after the implant has been inserted if it is desirable to arrange the longitudinal axis of the implant transversely to the viewing direction of the eye.
- the implant is normally inserted into the eye lengthways in the viewing direction of the eye by means of a scleral cut.
- the implant does not rotate spontaneously in the eye.
- the implant housing can be provided with suture loops on the outside for fixing the implant in the eye.
- the fastening could, for example, be designed such that closure of the implantation suture is used at the same time to fix the implant in place.
- a suture loop could be provided at the point where the implantation aperture is closed using a suture.
- an adhesion option can be provided on the implant, by means of which said implant is fixed in place as soon as the implantation aperture is closed using a biological adhesive.
- the implant housing is moulded from plastics material.
- the inner components such as the microchip, pressure sensor and antenna, etc. can be cast and fixed in the plastics material.
- moulding the housing from plastics material allows it to be shaped in a particularly simple manner, in particular into an ellipsoid or cuboid having rounded corners and edges.
- the implant could be coated with a pharmacologically active substance, e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
- a pharmacologically active substance e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
- the housing can be concave on the outer housing side thereof facing the choroid, as a result of which in particular deformation of the implant or mechanical tension caused by the eye, which would distort the pressure measurement, is prevented.
- Embodiments having straight or convex outer housing sides are also included in the invention.
- the implant housing comprises three nubs on the outer housing side thereof facing the sclera, which nubs are arranged in the manner of the corners of a triangle and are intended to come into contact with the sclera.
- the shape of the nubs can be round or pointed and thus form a soft “thorn” which prevents dislocation and torsion of the implant.
- the nubs also ensure that the implant cannot tilt and that no part of the implant other than the nubs comes into contact with the concave inner surface of the sclera. As a result, it is not necessary to adapt the outer contour of the sclera-side of the implant to different eye sizes. It has been found that the mechanical tension in the implant caused by bending can be greatly reduced by the arrangement of the nubs according to the invention.
- the invention is further improved by providing the implant with an electronic temperature sensor that is connected to the microchip and is intended for measuring the temperature of the eye, the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye.
- the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye.
- a further embodiment of the invention provides for the antenna to consist of an electrical coil that surrounds the microchip provided with the pressure sensor.
- a telemetry coil of this type is particularly well suited for transmitting data to a receiver arranged outside the eye.
- the coil can be produced by electroplating in that a plurality of layers of the coil are electrodeposited onto a flexible or rigid, but thin, substrate.
- Another embodiment consists of a thin insulated gold wire that is wound around the microchip directly or on integrated spacers. This gives the external coil arranged outside the eye a shape that allows optimal transformer coupling to the implant.
- the contour of the external coil can be two-dimensionally or three-dimensionally adapted to the position of the electrical coil in the implant.
- the microchip in the implant can thus be designed in the manner of a RFID chip, such that the implant does not need a separate battery as a power source.
- the energy for transmitting the data from the implant to the external receiver is provided by means of the receiving antenna itself emitting a brief energy burst that is temporarily stored in the microchip of the implant for a short time in order to provide the energy for the subsequent transmission process.
- the energy can also be supplied continuously throughout the measurement or data transmission process.
- the implant can operate in the manner of an active RFID tag and carry out measurements autonomously, the results of which are saved and only transmitted to an occasionally used reader upon request.
- the implant requires an energy store that is charged by means of transformer coupling or energy harvesting (saccades) for example, or also by means of optical cells that are sensitive to wavelengths for which the human sclera is transparent.
- An autonomous system of this type would either have its own clock generator or would use the frequencies of ubiquitous GSM signals as the clock frequency.
- the reader could provide the trigger for a measurement via a radio link. No short-range transformer coupling is necessary for this. It is sufficient for the reader to be positioned at a distance of approximately one metre from the implant.
- the reader measures and records the external air pressure together with and at the same time as the measurement values for the intraocular pressure.
- a quasi-continuous recording of air pressure values can also be achieved without any contact with the implant if said implant saves the measured intraocular pressure values together with a time stamp, for example in a data logger. After the occasional reading of the data logger, the measurement values for the intraocular pressure can be assigned to the same point in time as the air pressure values measured and recorded by the reader.
- An implant 1 according to the invention is shown in all figures and is intended to be implanted in an animal or human eye 2 .
- the outer wall of the eye 2 is formed by the sclera 3 , the inner side of which is adjacent to the choroid 4 that lies beneath it.
- the implant 1 lies in a cavity 5 that is shaped like a pocket and is formed in the suprachoroidal region between the sclera 3 and the choroid 4 .
- the implant 1 can be positioned ab interno transversely through the anterior chamber of the eye 2 by means of a surgical approach through the iridocorneal angle to the implantation site.
- the implant can be positioned through the sclera 3 by making the smallest incision possible, in practice approximately 5 mm long, through the sclera 3 .
- the incision can either extend directly perpendicularly, which may require subsequent wound closure, or it can be a lamellar incision and therefore self-closing.
- the incision is made in the region of or behind the pars plana, for example in parallel with the ora serrata.
- a cavity or pocket 5 is formed in the suprachoroidal space between the sclera 3 and the choroid 4 , using a viscoelastics material such as hyaluronic acid which is injected using an atraumatic cannula.
- the implant 1 can now be introduced into the pocket 5 using forceps or the insertion tool 20 described below. If required, the implant 1 is rotated inside the pocket 5 in the direction of rotation 32 by 90° about its vertical axis, which is possible due to the fact that the different layers of the eyeball merely lie on top of one another but are not stuck together.
- the stability of the eye's shape is due to the intraocular pressure.
- Rotating the implant has the advantage of allowing the telemetry coil 8 contained in the implant to be brought into an advantageous position, as far forward as possible and directly behind the pars plana, the long side being in parallel therewith.
- the implant 1 is thus either in parallel with the viewing direction 9 and therefore aligned with the optical axis of the eye 2 , or it is rotated by 90° relative to the viewing direction 9 and therefore oriented in parallel with the pars plana.
- the aim is to position the implant as far forward as possible so that it can be reached as easily as possible by the telemetry.
- the surgically produced sclera aperture does not necessarily have to be closed after the implant 1 has been positioned. Normally, the sclera will grow back of its own accord without further intervention. If required, however, it can be closed by means of a suture, biological adhesive, or the like.
- the implant 1 has an electrical pressure sensor 6 for measuring the intraocular pressure, a microchip 7 on which the pressure sensor 6 is attached and connected to the microchip 7 , and an antenna 8 in the form of an electrical coil that is made of insulating gold wire and supported by spacers 10 .
- the gold wire is wound around the microchip 7 in a plurality of turns.
- the housing 11 of the implant 1 is moulded from synthetic resin or formed of silicone rubber, the above-mentioned components being enclosed therein.
- the implant could, for example, be embedded in a plurality of layers of silicone rubber having varying degrees of hardness in order to achieve greater stability.
- a sensor-side layer is made of softer material and a back layer is made of harder material.
- the housing 11 is flat and elongate and is in the shape of a cuboid having rounded corners and edges, and nubs on one housing side.
- the length 12 of the housing 11 is approximately 6 mm, its width 13 is approximately 3 mm and its thickness 14 is approximately 1.5 mm.
- the housing 11 is provided with three nubs 17 on an outer housing side 15 that faces the sclera 3 of the eye 2 in the implanted state, the nubs being arranged in the manner of the corners of a triangle.
- the same implant 1 can be used for eyes 2 of varying sizes, the sclera 3 of which is concavely curved to varying degrees on its inner side without the degree of curvature having a significant influence on the mechanical tension to which the implant 1 is exposed in the eye 2 .
- the accuracy of the pressure measurement is improved.
- the pressure sensor 6 is arranged on the other outer housing side 16 of the housing 11 that faces the choroid 4 in the implanted state.
- a flexible membrane 18 is located between the pressure sensor 6 and the choroid 4 as a protective layer against ingress of liquid. The membrane 18 presses against the pressure-sensitive surface of the pressure sensor 6 and, on the other side, against the choroid 4 . The pressure sensor 6 is thus in full-surface contact with the choroid 4 via the membrane 18 .
- the implant 1 lies in the eye 2 in a tension-free manner between the sclera 3 and the choroid 4 . Due to physiological ocular pressure and force relationships, the intraocular pressure also fixes the implant 1 in place by means of the choroid 4 .
- the choroid 4 lies on the membrane 18 of the planarly extended pressure sensor 6 as a thin, soft choroid coat. As a result, the coupling between the pressure sensor 6 and the aqueous humour of the vitreous body of the eye 2 is not, or is only insignificantly, affected.
- the implant 1 therefore does not measure the pressure in the suprachoroidal space, but rather in the inner eye.
- the implant 1 is provided with a temperature sensor 19 that is attached to the microchip 7 .
- the temperature sensor 19 is used for measuring the temperature of the eye in the suprachoroidal space.
- the electrical signals of the temperature sensor 19 are registered by the microchip 7 and digital data are generated in which the temperature values and pressure values are encoded.
- the digital data are transmitted by the antenna 8 , using electromagnetic waves, to a receiver located outside the eye 2 .
- the pressure and temperature data can be saved in and analysed by the receiver. Analysis of the temporal progression of the pressure or temperature is thus also possible.
- the outer housing side 16 of the housing 11 of the implant 1 that faces the choroid can be concave.
- the outer housing side 15 of the housing 11 opposite the sclera 3 is convex in the embodiment shown.
- the design can take one form or the other, depending on the requirements.
- the convex and concave sides can also be arranged vice versa, or both sides can be convex or both sides can be concave.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Ophthalmology & Optometry (AREA)
- Physiology (AREA)
- Prostheses (AREA)
- Eye Examination Apparatus (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
- The present invention relates to an implant for determining intraocular pressure, comprising at least one electronic pressure sensor for measuring the intraocular pressure, at least one microchip that is connected to the pressure sensor, and at least one antenna that is connected to the microchip, the microchip generating digitally encoded data from the electrical signals of the pressure sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye, and said components being accommodated in a small housing, the outer dimensions of which are limited such that the implant can be positioned between the sclera and choroid of the eye.
- U.S. Pat. No. 8,475,374 B2 discloses an implant of this type. This known implant comprises an artificial drainage tube or is in contact with an artificial drainage tube for watery ocular fluid in order to measure the pressure of the outflowing ocular fluid. However, an artificial drainage tube is associated with a considerable and risky intervention in the eye.
- DE 197 28 069 C1 discloses an implant in which the pressure sensor is contained in an implantable intraocular lens that is inserted into the eye in place of the natural lens. This known implant is therefore not suitable for cases where the natural lens of the eye should be retained.
- U.S. Pat. No. 7,824,423 B2 discloses a surgical tool for inserting implants into the eye. Moreover, this US patent discloses inserting implants into the eye that are used for scleral prosthesis and that increase the working range of the ciliary muscles in a purely mechanical manner in order to make it easier for the eye treated in this way to focus on nearby objects if the amplitude of accommodation has already declined due to age.
- The object of the invention is to provide an implant for determining intraocular pressure that can be implanted into the eye with little intervention and that transmits measurement data of the highly accurately measured intraocular pressure to a receiver located outside the eye.
- This object is achieved by the invention in that the pressure sensor is accommodated on the outer housing side that is brought into contact with the choroid in the eye. The implant according to the invention can be implanted into human or animal eyes in a minimally invasive manner and can remain there as a long-term implant. The implant is designed according to the invention such that it can be accommodated in a suprachoroidal cavity of the eye created for positioning the implant between the sclera and choroid, where said implant does not interfere with the functioning of the eye. Neither an artificial lens nor an artificial drainage tube for the ocular fluid is necessary. Nevertheless, the contact of the pressure sensor on the choroid ensures that the intraocular pressure is applied to the pressure sensor and can be measured accurately.
- The implantation is carried out either by means of a separate implantation procedure or in combination with other ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
- In a development of the invention it is provided for the outer housing side equipped with the pressure sensor to comprise a flexible membrane in the region of the pressure sensor as a protective layer against ingress of fluid, the intraocular pressure acting on the pressure sensor via the choroid and the membrane. The flexible membrane ensures precise transfer of the intraocular pressure, which could otherwise be distorted by housing-induced mechanical tensions if a less flexible housing material were used.
- In a preferred embodiment, the implant housing is flat and elongate, preferably in the form of an ellipsoid or cuboid having rounded corners and edges. By rounding off the edges and corners, eye injuries can be prevented. In order to preserve ocular integrity, the implant must be as flat as possible, since relatively little space can be created between the sclera and the choroid. The thickness of the implant is therefore the smallest dimension thereof and should be less than 2 mm if possible.
- The front face should not be too big either, in order for the scleral incision necessary for inserting the implant to be as small as possible. The width of the implant is therefore preferably less than 3.5 mm.
- The largest dimension is the length of the implant, which should preferably be less than 7 mm in order to minimise the biomechanical influences on the eye as well as on the implant.
- Due to its flat shape, the implant cannot rotate about its longitudinal axis within the pocket between the sclera and choroid in the eye. Only rotations about the vertical axis (see direction of
rotation 32 inFIG. 3 ) are possible. These rotations can be performed after the implant has been inserted if it is desirable to arrange the longitudinal axis of the implant transversely to the viewing direction of the eye. The implant is normally inserted into the eye lengthways in the viewing direction of the eye by means of a scleral cut. - Usually, the implant does not rotate spontaneously in the eye. If, exceptionally, there is nonetheless a risk of rotation, the implant housing can be provided with suture loops on the outside for fixing the implant in the eye. The fastening could, for example, be designed such that closure of the implantation suture is used at the same time to fix the implant in place. For this purpose, a suture loop could be provided at the point where the implantation aperture is closed using a suture. Alternatively, an adhesion option can be provided on the implant, by means of which said implant is fixed in place as soon as the implantation aperture is closed using a biological adhesive.
- In a preferred embodiment the implant housing is moulded from plastics material. In this way, the inner components such as the microchip, pressure sensor and antenna, etc. can be cast and fixed in the plastics material. Furthermore, moulding the housing from plastics material allows it to be shaped in a particularly simple manner, in particular into an ellipsoid or cuboid having rounded corners and edges.
- The implant could be coated with a pharmacologically active substance, e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
- In a variant, the housing can be concave on the outer housing side thereof facing the choroid, as a result of which in particular deformation of the implant or mechanical tension caused by the eye, which would distort the pressure measurement, is prevented. Embodiments having straight or convex outer housing sides are also included in the invention.
- The shape of the implant side facing the inner surface of the sclera can lead to unexpected variations in the pressure measurement, e.g. as a result of cell proliferation or encapsulation reactions of the body. It is therefore proposed for the implant housing to comprise three nubs on the outer housing side thereof facing the sclera, which nubs are arranged in the manner of the corners of a triangle and are intended to come into contact with the sclera. The shape of the nubs can be round or pointed and thus form a soft “thorn” which prevents dislocation and torsion of the implant. The nubs also ensure that the implant cannot tilt and that no part of the implant other than the nubs comes into contact with the concave inner surface of the sclera. As a result, it is not necessary to adapt the outer contour of the sclera-side of the implant to different eye sizes. It has been found that the mechanical tension in the implant caused by bending can be greatly reduced by the arrangement of the nubs according to the invention.
- The invention is further improved by providing the implant with an electronic temperature sensor that is connected to the microchip and is intended for measuring the temperature of the eye, the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye. Specifically, scientific investigations have found that there can be steep temperature gradients inside the eye. The temperature measured in the anterior chamber or in the posterior chamber is thus different from the suprachoroidal temperature. This suprachoroidal temperature can be measured and recorded together with the hydrostatic and hydrodynamic fluid pressure in the eye using the implant according to the invention. Supplementing the pressure monitoring with temperature monitoring allows better conclusions to be drawn regarding ocular pathologies or general diseases, for example diseases of the retina or disorders of general thermoregulation of the patient.
- A further embodiment of the invention provides for the antenna to consist of an electrical coil that surrounds the microchip provided with the pressure sensor. A telemetry coil of this type is particularly well suited for transmitting data to a receiver arranged outside the eye. The coil can be produced by electroplating in that a plurality of layers of the coil are electrodeposited onto a flexible or rigid, but thin, substrate.
- Another embodiment consists of a thin insulated gold wire that is wound around the microchip directly or on integrated spacers. This gives the external coil arranged outside the eye a shape that allows optimal transformer coupling to the implant. The contour of the external coil can be two-dimensionally or three-dimensionally adapted to the position of the electrical coil in the implant.
- The microchip in the implant can thus be designed in the manner of a RFID chip, such that the implant does not need a separate battery as a power source. The energy for transmitting the data from the implant to the external receiver is provided by means of the receiving antenna itself emitting a brief energy burst that is temporarily stored in the microchip of the implant for a short time in order to provide the energy for the subsequent transmission process.
- However, the energy can also be supplied continuously throughout the measurement or data transmission process.
- In an alternative embodiment, the implant can operate in the manner of an active RFID tag and carry out measurements autonomously, the results of which are saved and only transmitted to an occasionally used reader upon request. In this case, the implant requires an energy store that is charged by means of transformer coupling or energy harvesting (saccades) for example, or also by means of optical cells that are sensitive to wavelengths for which the human sclera is transparent. An autonomous system of this type would either have its own clock generator or would use the frequencies of ubiquitous GSM signals as the clock frequency. The reader could provide the trigger for a measurement via a radio link. No short-range transformer coupling is necessary for this. It is sufficient for the reader to be positioned at a distance of approximately one metre from the implant.
- It is particularly expedient if the reader measures and records the external air pressure together with and at the same time as the measurement values for the intraocular pressure. A quasi-continuous recording of air pressure values can also be achieved without any contact with the implant if said implant saves the measured intraocular pressure values together with a time stamp, for example in a data logger. After the occasional reading of the data logger, the measurement values for the intraocular pressure can be assigned to the same point in time as the air pressure values measured and recorded by the reader.
- Embodiments of the invention are explained in more detail below with reference to the figures, in which, in detail:
-
-
FIG. 1 is a cross section of an eye comprising an inserted implant; -
FIG. 2 is a detail A fromFIG. 1 comprising the implant inserted in a pocket between the sclera and choroid; -
FIG. 3 is a greatly enlarged plan view of an implant according to the invention; -
FIG. 4 is a side view of the implant fromFIG. 3 ; -
FIG. 5 is a side view of a second embodiment of the implant having concave and convex lateral faces.
-
- An implant 1 according to the invention is shown in all figures and is intended to be implanted in an animal or
human eye 2. The outer wall of theeye 2 is formed by thesclera 3, the inner side of which is adjacent to the choroid 4 that lies beneath it. As can be seen best inFIG. 2 , the implant 1 lies in acavity 5 that is shaped like a pocket and is formed in the suprachoroidal region between thesclera 3 and the choroid 4. - The implant 1 can be positioned ab interno transversely through the anterior chamber of the
eye 2 by means of a surgical approach through the iridocorneal angle to the implantation site. Alternatively, the implant can be positioned through thesclera 3 by making the smallest incision possible, in practice approximately 5 mm long, through thesclera 3. In this way, the incision can either extend directly perpendicularly, which may require subsequent wound closure, or it can be a lamellar incision and therefore self-closing. The incision is made in the region of or behind the pars plana, for example in parallel with the ora serrata. Subsequently, a cavity orpocket 5 is formed in the suprachoroidal space between thesclera 3 and the choroid 4, using a viscoelastics material such as hyaluronic acid which is injected using an atraumatic cannula. The implant 1 can now be introduced into thepocket 5 using forceps or the insertion tool 20 described below. If required, the implant 1 is rotated inside thepocket 5 in the direction ofrotation 32 by 90° about its vertical axis, which is possible due to the fact that the different layers of the eyeball merely lie on top of one another but are not stuck together. - The stability of the eye's shape is due to the intraocular pressure. Rotating the implant has the advantage of allowing the telemetry coil 8 contained in the implant to be brought into an advantageous position, as far forward as possible and directly behind the pars plana, the long side being in parallel therewith. The implant 1 is thus either in parallel with the
viewing direction 9 and therefore aligned with the optical axis of theeye 2, or it is rotated by 90° relative to theviewing direction 9 and therefore oriented in parallel with the pars plana. The aim is to position the implant as far forward as possible so that it can be reached as easily as possible by the telemetry. - The surgically produced sclera aperture does not necessarily have to be closed after the implant 1 has been positioned. Normally, the sclera will grow back of its own accord without further intervention. If required, however, it can be closed by means of a suture, biological adhesive, or the like.
- As can be seen best in
FIGS. 3 and 4 , the implant 1 has anelectrical pressure sensor 6 for measuring the intraocular pressure, amicrochip 7 on which thepressure sensor 6 is attached and connected to themicrochip 7, and an antenna 8 in the form of an electrical coil that is made of insulating gold wire and supported byspacers 10. The gold wire is wound around themicrochip 7 in a plurality of turns. Thehousing 11 of the implant 1 is moulded from synthetic resin or formed of silicone rubber, the above-mentioned components being enclosed therein. In particular, the implant could, for example, be embedded in a plurality of layers of silicone rubber having varying degrees of hardness in order to achieve greater stability. In this case, a sensor-side layer is made of softer material and a back layer is made of harder material. Thehousing 11 is flat and elongate and is in the shape of a cuboid having rounded corners and edges, and nubs on one housing side. Thelength 12 of thehousing 11 is approximately 6 mm, itswidth 13 is approximately 3 mm and its thickness 14 is approximately 1.5 mm. Thehousing 11 is provided with threenubs 17 on anouter housing side 15 that faces thesclera 3 of theeye 2 in the implanted state, the nubs being arranged in the manner of the corners of a triangle. As a result, the same implant 1 can be used foreyes 2 of varying sizes, thesclera 3 of which is concavely curved to varying degrees on its inner side without the degree of curvature having a significant influence on the mechanical tension to which the implant 1 is exposed in theeye 2. As a result, the accuracy of the pressure measurement is improved. - The
pressure sensor 6 is arranged on the otherouter housing side 16 of thehousing 11 that faces the choroid 4 in the implanted state. Aflexible membrane 18 is located between thepressure sensor 6 and the choroid 4 as a protective layer against ingress of liquid. Themembrane 18 presses against the pressure-sensitive surface of thepressure sensor 6 and, on the other side, against the choroid 4. Thepressure sensor 6 is thus in full-surface contact with the choroid 4 via themembrane 18. - The implant 1 lies in the
eye 2 in a tension-free manner between thesclera 3 and the choroid 4. Due to physiological ocular pressure and force relationships, the intraocular pressure also fixes the implant 1 in place by means of the choroid 4. The choroid 4 lies on themembrane 18 of the planarlyextended pressure sensor 6 as a thin, soft choroid coat. As a result, the coupling between thepressure sensor 6 and the aqueous humour of the vitreous body of theeye 2 is not, or is only insignificantly, affected. The implant 1 therefore does not measure the pressure in the suprachoroidal space, but rather in the inner eye. - Furthermore, the implant 1 is provided with a
temperature sensor 19 that is attached to themicrochip 7. Thetemperature sensor 19 is used for measuring the temperature of the eye in the suprachoroidal space. Just like the electrical signals of thepressure sensor 6, the electrical signals of thetemperature sensor 19 are registered by themicrochip 7 and digital data are generated in which the temperature values and pressure values are encoded. The digital data are transmitted by the antenna 8, using electromagnetic waves, to a receiver located outside theeye 2. The pressure and temperature data can be saved in and analysed by the receiver. Analysis of the temporal progression of the pressure or temperature is thus also possible. - In a variant, as shown in
FIG. 5 , theouter housing side 16 of thehousing 11 of the implant 1 that faces the choroid can be concave. Theouter housing side 15 of thehousing 11 opposite thesclera 3 is convex in the embodiment shown. The design can take one form or the other, depending on the requirements. Thus, the convex and concave sides can also be arranged vice versa, or both sides can be convex or both sides can be concave. -
- 1 Implant
- 2 Eye
- 3 Sclera
- 4 Choroid
- 5 Pocket/cavity
- 6 Pressure sensor
- 7 Microchip
- 8 Antenna/coil
- 9 Viewing direction
- 10 Spacer
- 11 Housing
- 12 Length
- 13 Width
- 14 Thickness
- 15 Outer housing side
- 16 Outer housing side
- 17 Nubs
- 18 Membrane
- 19 Temperature sensor
Claims (15)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014212457.3 | 2014-06-27 | ||
| DE102014212457.3A DE102014212457A1 (en) | 2014-06-27 | 2014-06-27 | Implant for the determination of intraocular pressure |
| PCT/EP2015/062976 WO2015197364A1 (en) | 2014-06-27 | 2015-06-10 | Implant for determining intraocular pressure |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2015/062976 A-371-Of-International WO2015197364A1 (en) | 2014-06-27 | 2015-06-10 | Implant for determining intraocular pressure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/375,711 Continuation US12318143B2 (en) | 2014-06-27 | 2021-07-14 | Implant for determining intraocular pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20170127941A1 true US20170127941A1 (en) | 2017-05-11 |
Family
ID=53373462
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/319,294 Abandoned US20170127941A1 (en) | 2014-06-27 | 2015-06-10 | Implant for determining intraocular pressure |
| US17/375,711 Active US12318143B2 (en) | 2014-06-27 | 2021-07-14 | Implant for determining intraocular pressure |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/375,711 Active US12318143B2 (en) | 2014-06-27 | 2021-07-14 | Implant for determining intraocular pressure |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20170127941A1 (en) |
| EP (1) | EP3975822A1 (en) |
| JP (1) | JP2017522155A (en) |
| AU (1) | AU2015281158B2 (en) |
| CA (1) | CA2950819A1 (en) |
| DE (1) | DE102014212457A1 (en) |
| WO (1) | WO2015197364A1 (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019068026A1 (en) | 2017-09-29 | 2019-04-04 | Glaukos Corporation | Intraocular physiological sensor |
| US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
| US11197779B2 (en) | 2015-08-14 | 2021-12-14 | Ivantis, Inc. | Ocular implant with pressure sensor and delivery system |
| CN114569063A (en) * | 2022-04-24 | 2022-06-03 | 明澈生物科技(苏州)有限公司 | Intraocular pressure sensor |
| US20220211269A1 (en) * | 2014-07-01 | 2022-07-07 | Injectsense, Inc. | Methods and Devices for Implantation of Intraocular Pressure Sensors |
| US11497399B2 (en) | 2016-05-31 | 2022-11-15 | Qura, Inc. | Implantable intraocular pressure sensors and methods of use |
| US11540940B2 (en) | 2021-01-11 | 2023-01-03 | Alcon Inc. | Systems and methods for viscoelastic delivery |
| US11744734B2 (en) | 2007-09-24 | 2023-09-05 | Alcon Inc. | Method of implanting an ocular implant |
| US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
| US12029683B2 (en) | 2018-02-22 | 2024-07-09 | Alcon Inc. | Ocular implant and delivery system |
| US12042432B1 (en) | 2024-01-11 | 2024-07-23 | Michael Reynard | Method and device for the treatment of glaucoma |
| CN119499038A (en) * | 2023-08-25 | 2025-02-25 | 苏州朗目医疗科技有限公司 | Eye implant |
| US12274640B1 (en) | 2024-11-08 | 2025-04-15 | Michael Reynard | Implant for electrolysis of aqueous humor |
| US12419738B2 (en) | 2010-02-23 | 2025-09-23 | Alcon Inc. | Fluid for accommodating intraocular lenses |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4193907A1 (en) | 2011-09-13 | 2023-06-14 | Glaukos Corporation | Intraocular physiological sensor |
| US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
| WO2017164982A1 (en) * | 2016-03-21 | 2017-09-28 | The Regents Of The University Of California | Real-time and continuous measurement in vivo using aptamer-based biosensors |
| DE102017107579A1 (en) | 2017-04-07 | 2018-10-11 | Implandata Ophthalmic Products Gmbh | Partially flexible device for determining intraocular pressure for implantation in the human body |
| WO2019219193A1 (en) | 2018-05-16 | 2019-11-21 | Implandata Ophthalmic Products Gmbh | Partially flexible device for determining interocular pressure for implanting in the human body |
| US11701019B2 (en) * | 2019-03-27 | 2023-07-18 | Glaukos Corporation | Intraocular physiological sensor |
| DE102019119913A1 (en) * | 2019-07-23 | 2021-01-28 | Implandata Ophthalmic Products Gmbh | Arrangement and method for capturing a field of view and use of an implant |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4253199A (en) * | 1978-09-25 | 1981-03-03 | Surgical Design Corporation | Surgical method and apparatus for implants for the eye |
| US4642114A (en) * | 1983-05-16 | 1987-02-10 | Rosa Daniele S A | Posterior chamber intraocular lens |
| US5520631A (en) * | 1994-07-22 | 1996-05-28 | Wound Healing Of Oklahoma | Method and apparatus for lowering the intraocular pressure of an eye |
| US20030078487A1 (en) * | 2001-08-09 | 2003-04-24 | Jeffries Robert E. | Ocular pressure measuring device |
| US20040059248A1 (en) * | 2001-01-17 | 2004-03-25 | Arthur Messner | Implant for determining intra-ocular pressure |
| US6939299B1 (en) * | 1999-12-13 | 2005-09-06 | Kurt Petersen | Implantable continuous intraocular pressure sensor |
| US20110248671A1 (en) * | 2010-04-08 | 2011-10-13 | Alcon Research, Ltd. | Power System Implantable in Eye |
| US20120004528A1 (en) * | 2010-07-02 | 2012-01-05 | Alcon Research, Ltd. | Implantable Remote Monitoring Sensor |
| US20120226133A1 (en) * | 2009-09-18 | 2012-09-06 | Orthomems, Inc. | Implantable mems intraocular pressure sensor devices and methods for glaucoma monitoring |
| US20140275923A1 (en) * | 2013-03-13 | 2014-09-18 | David S. Haffner | Intraocular physiological sensor |
| US8926510B2 (en) * | 2011-04-27 | 2015-01-06 | Istar Medical Sa | Device and method for glaucoma management and treatment |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19728069C1 (en) | 1997-07-01 | 1999-02-11 | Acritec Gmbh | Device for measuring intraocular pressure |
| AR032840A1 (en) | 2001-02-23 | 2003-11-26 | Ras Holding Corp | SURGICAL SHEET USED WITH A SURGICAL INSTRUMENT TO MAKE INCISIONS IN IMPLANTS IN EYE SCLERTIC |
| US20050159660A1 (en) * | 2002-05-31 | 2005-07-21 | Valentino Montegrande | Intraocular pressure sensor |
| JP4258657B2 (en) * | 2002-08-08 | 2009-04-30 | グローコス コーポレーション | Implantable eye pump to reduce intraocular pressure |
| WO2005027906A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| US8475374B2 (en) * | 2007-08-23 | 2013-07-02 | Purdue Research Foundation | Intra-occular pressure sensor |
| JP2013505078A (en) * | 2009-09-18 | 2013-02-14 | オーソメムス, インコーポレイテッド | Implantable ophthalmic MEMS sensor device and method for ophthalmic surgery |
| US20120022505A1 (en) * | 2010-07-20 | 2012-01-26 | Bruno Dacquay | Closed loop glaucoma drug delivery system |
| DE102010035294A1 (en) * | 2010-08-25 | 2011-12-22 | Implandata Ophthalmic Products Gmbh | Sclera sensor |
| KR20140089506A (en) * | 2011-06-30 | 2014-07-15 | 엔도트로닉스, 인코포레이티드 | Implantable sensor enclosure with thin sidewalls |
| EP4193907A1 (en) * | 2011-09-13 | 2023-06-14 | Glaukos Corporation | Intraocular physiological sensor |
| US9339187B2 (en) * | 2011-12-15 | 2016-05-17 | Alcon Research, Ltd. | External pressure measurement system and method for an intraocular implant |
| US9046699B2 (en) * | 2012-03-13 | 2015-06-02 | Johnson & Johnson Vision Care, Inc. | Dynamic fluid zones in contact lenses |
| US9486132B2 (en) | 2013-01-17 | 2016-11-08 | Abbott Cardiovascular Systems, Inc. | Access device for accessing tissue |
| WO2015085234A1 (en) * | 2013-12-06 | 2015-06-11 | Forsight Vision4, Inc. | Implantable therapeutic devices |
-
2014
- 2014-06-27 DE DE102014212457.3A patent/DE102014212457A1/en not_active Withdrawn
-
2015
- 2015-06-10 EP EP15727988.6A patent/EP3975822A1/en not_active Withdrawn
- 2015-06-10 JP JP2017519795A patent/JP2017522155A/en active Pending
- 2015-06-10 CA CA2950819A patent/CA2950819A1/en not_active Abandoned
- 2015-06-10 AU AU2015281158A patent/AU2015281158B2/en not_active Ceased
- 2015-06-10 WO PCT/EP2015/062976 patent/WO2015197364A1/en not_active Ceased
- 2015-06-10 US US15/319,294 patent/US20170127941A1/en not_active Abandoned
-
2021
- 2021-07-14 US US17/375,711 patent/US12318143B2/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4253199A (en) * | 1978-09-25 | 1981-03-03 | Surgical Design Corporation | Surgical method and apparatus for implants for the eye |
| US4642114A (en) * | 1983-05-16 | 1987-02-10 | Rosa Daniele S A | Posterior chamber intraocular lens |
| US5520631A (en) * | 1994-07-22 | 1996-05-28 | Wound Healing Of Oklahoma | Method and apparatus for lowering the intraocular pressure of an eye |
| US6939299B1 (en) * | 1999-12-13 | 2005-09-06 | Kurt Petersen | Implantable continuous intraocular pressure sensor |
| US20040059248A1 (en) * | 2001-01-17 | 2004-03-25 | Arthur Messner | Implant for determining intra-ocular pressure |
| US20030078487A1 (en) * | 2001-08-09 | 2003-04-24 | Jeffries Robert E. | Ocular pressure measuring device |
| US20120226133A1 (en) * | 2009-09-18 | 2012-09-06 | Orthomems, Inc. | Implantable mems intraocular pressure sensor devices and methods for glaucoma monitoring |
| US20110248671A1 (en) * | 2010-04-08 | 2011-10-13 | Alcon Research, Ltd. | Power System Implantable in Eye |
| US20120004528A1 (en) * | 2010-07-02 | 2012-01-05 | Alcon Research, Ltd. | Implantable Remote Monitoring Sensor |
| US8926510B2 (en) * | 2011-04-27 | 2015-01-06 | Istar Medical Sa | Device and method for glaucoma management and treatment |
| US20140275923A1 (en) * | 2013-03-13 | 2014-09-18 | David S. Haffner | Intraocular physiological sensor |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11744734B2 (en) | 2007-09-24 | 2023-09-05 | Alcon Inc. | Method of implanting an ocular implant |
| US12016796B2 (en) | 2007-09-24 | 2024-06-25 | Alcon Inc. | Methods and devices for increasing aqueous humor outflow |
| US12419738B2 (en) | 2010-02-23 | 2025-09-23 | Alcon Inc. | Fluid for accommodating intraocular lenses |
| US20220211269A1 (en) * | 2014-07-01 | 2022-07-07 | Injectsense, Inc. | Methods and Devices for Implantation of Intraocular Pressure Sensors |
| US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
| US11197779B2 (en) | 2015-08-14 | 2021-12-14 | Ivantis, Inc. | Ocular implant with pressure sensor and delivery system |
| US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
| US11497399B2 (en) | 2016-05-31 | 2022-11-15 | Qura, Inc. | Implantable intraocular pressure sensors and methods of use |
| AU2018338994B2 (en) * | 2017-09-29 | 2024-03-28 | Glaukos Corporation | Intraocular physiological sensor |
| US11857262B2 (en) | 2017-09-29 | 2024-01-02 | Glaukos Corporation | Intraocular physiological sensor |
| WO2019068026A1 (en) | 2017-09-29 | 2019-04-04 | Glaukos Corporation | Intraocular physiological sensor |
| EP3687374A4 (en) * | 2017-09-29 | 2021-07-07 | Glaukos Corporation | INTRAOCULAR PHYSIOLOGICAL SENSOR |
| CN111801045A (en) * | 2017-09-29 | 2020-10-20 | 格拉科斯公司 | Intraocular Physiological Sensors |
| US12029683B2 (en) | 2018-02-22 | 2024-07-09 | Alcon Inc. | Ocular implant and delivery system |
| US11540940B2 (en) | 2021-01-11 | 2023-01-03 | Alcon Inc. | Systems and methods for viscoelastic delivery |
| US12336933B2 (en) | 2021-01-11 | 2025-06-24 | Alcon Inc. | Systems and methods for viscoelastic delivery |
| CN114569063A (en) * | 2022-04-24 | 2022-06-03 | 明澈生物科技(苏州)有限公司 | Intraocular pressure sensor |
| US12257079B2 (en) | 2022-04-24 | 2025-03-25 | Mingche Biotechnology Co., Ltd | Intraocular pressure sensor |
| CN119499038A (en) * | 2023-08-25 | 2025-02-25 | 苏州朗目医疗科技有限公司 | Eye implant |
| US12042432B1 (en) | 2024-01-11 | 2024-07-23 | Michael Reynard | Method and device for the treatment of glaucoma |
| US12274640B1 (en) | 2024-11-08 | 2025-04-15 | Michael Reynard | Implant for electrolysis of aqueous humor |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015197364A1 (en) | 2015-12-30 |
| EP3975822A1 (en) | 2022-04-06 |
| CA2950819A1 (en) | 2015-12-30 |
| US12318143B2 (en) | 2025-06-03 |
| JP2017522155A (en) | 2017-08-10 |
| AU2015281158B2 (en) | 2019-07-25 |
| DE102014212457A1 (en) | 2015-12-31 |
| US20210361161A1 (en) | 2021-11-25 |
| AU2015281158A1 (en) | 2016-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12318143B2 (en) | Implant for determining intraocular pressure | |
| US20230024683A1 (en) | Implantable intraocular pressure sensors and methods of use | |
| US8894578B2 (en) | Implantable MEMs intraocular pressure sensor devices and methods for glaucoma monitoring | |
| US8182435B2 (en) | Intraocular pressure sensor | |
| JP6133294B2 (en) | Processor-controlled intraocular lens system | |
| ES2973275T3 (en) | Systems to monitor eye health | |
| US10213107B2 (en) | Methods and devices for implantation of intraocular pressure sensors | |
| US8527055B2 (en) | Application of an electrical field in the vicinity of the trabecular meshwork to treat glaucoma | |
| WO2012037455A1 (en) | Expandable implantable pressure sensor for intraocular surgery | |
| US20040098123A1 (en) | Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma | |
| ES3034161T3 (en) | Electrical apparatus for an eye | |
| JP2017520337A (en) | Ultra-low power rechargeable implantable sensor with wireless interface for patient monitoring | |
| JP2004520119A (en) | Implants for determining intraocular pressure | |
| US20120004528A1 (en) | Implantable Remote Monitoring Sensor | |
| ES2812814T3 (en) | Intraocular device with wirelessly coupled auxiliary electronics | |
| WO2012157623A1 (en) | Intraocular lens | |
| US12042432B1 (en) | Method and device for the treatment of glaucoma | |
| US10863903B2 (en) | Ocular system and method | |
| US20250228707A1 (en) | Method and Device for the Treatment of Glaucoma | |
| ES2556008T3 (en) | Stirrup prosthesis with spring closure | |
| JP7104694B2 (en) | Intraocular implant | |
| US12208258B2 (en) | Electrical apparatus and methods for an eye | |
| CN107427362A (en) | Noninvasive vestibular stimulation and measuring electrode |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: IMPLANDATA OPHTHALMIC PRODUCTS GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OSTERMEIER, MAX;MEYER, STEFAN;SZURMAN, PROF. PETER;REEL/FRAME:040637/0179 Effective date: 20161128 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |